Unnamed: 0
int64 0
1.41M
| headline
stringlengths 3
513
| url
stringlengths 33
162
| publisher
stringlengths 3
46
| date
timestamp[s] | stock
stringlengths 1
5
|
|---|---|---|---|---|---|
1,412,221 | Stocks Which Set New 52-Week High Yesterday, August 2nd | https://www.benzinga.com/trading-ideas/technicals/18/08/12138981/stocks-which-set-new-52-week-high-yesterday-august-2nd | Benzinga Newsdesk | 2018-08-03T00:00:00 | ZTS |
1,412,222 | Stifel Nicolaus Maintains Buy on Zoetis, Raises Price Target to $95 | https://www.benzinga.com/news/18/08/12137242/stifel-nicolaus-maintains-buy-on-zoetis-raises-price-target-to-95 | Vick Meyer | 2018-08-03T00:00:00 | ZTS |
1,412,223 | The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings | https://www.benzinga.com/general/biotech/18/08/12136788/the-daily-biotech-pulse-zafgen-executive-departs-adamas-acceleron-acc | Shanthi Rexaline | 2018-08-03T00:00:00 | ZTS |
1,412,224 | Morgan Stanley Maintains Equal-Weight on Zoetis, Raises Price Target to $92 | https://www.benzinga.com/news/18/08/12136997/morgan-stanley-maintains-equal-weight-on-zoetis-raises-price-target-to-92 | Vick Meyer | 2018-08-03T00:00:00 | ZTS |
1,412,225 | Stocks That Made New 52 Week Highs So Far Today Include: PerkinElmer, Eli Lilly, Zoetis, Apple, Simon Property Group, Global Payments, and Church & Dwight | https://www.benzinga.com/trading-ideas/technicals/18/08/12129601/stocks-that-made-new-52-week-highs-so-far-today-include-perk | Benzinga Newsdesk | 2018-08-02T00:00:00 | ZTS |
1,412,226 | The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter | https://www.benzinga.com/general/biotech/18/08/12125416/the-daily-biotech-pulse-denalis-parkinsons-candidate-clears-early-sta | Shanthi Rexaline | 2018-08-02T00:00:00 | ZTS |
1,412,227 | Zoetis Narrows FY18 Guidance: Adj. EPS From $2.96-$3.10 To $3-$3.10 vs $3.06 Estimate, Sales From $5.675B-$5.8B To $5.7B-$5.8B vs $5.74B Est. | https://www.benzinga.com/news/18/08/12126381/zoetis-narrows-fy18-guidance-adj-eps-from-2-96-3-10-to-3-3-10-vs-3-06-estimate-s | Benzinga Newsdesk | 2018-08-02T00:00:00 | ZTS |
1,412,228 | Zoetis Q2 EPS $0.77 Beats $0.70 Estimate, Sales $1.415B Beat $1.38B Estimate | https://www.benzinga.com/news/earnings/18/08/12126372/zoetis-q2-eps-0-77-beats-0-70-estimate-sales-1-415b-beat-1-38b-estimate | Benzinga Newsdesk | 2018-08-02T00:00:00 | ZTS |
1,412,229 | Earnings Scheduled For August 2, 2018 | https://www.benzinga.com/news/earnings/18/08/12125441/earnings-scheduled-for-august-2-2018 | Lisa Levin | 2018-08-02T00:00:00 | ZTS |
1,412,230 | Zoetis Q2 Earnings Preview | https://www.benzinga.com/news/earnings-previews/18/08/12120291/zoetiss-earnings-roundup | Benzinga Newsdesk | 2018-08-01T00:00:00 | ZTS |
1,412,231 | Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial | https://www.benzinga.com/general/biotech/18/08/12114456/benzingas-biotech-pulse-pfizers-xeljanz-gets-eu-nod-newlink-losses-na | Shanthi Rexaline | 2018-08-01T00:00:00 | ZTS |
1,412,232 | Zoetis Files S-3ASR For A Mixed Shelf Offering | https://www.benzinga.com/news/18/07/12109967/zoetis-files-s-3asr-for-a-mixed-shelf-offering | Benzinga_Newsdesk | 2018-07-31T00:00:00 | ZTS |
1,412,233 | The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs | https://www.benzinga.com/general/biotech/18/07/12083481/the-week-ahead-in-biotech-conferences-pdufa-dates-earnings-and-ipos | Shanthi Rexaline | 2018-07-28T00:00:00 | ZTS |
1,412,234 | Zoetis, Abaxis Receive Hart-Scott-Rodino Antitrust Clearance For Deal | https://www.benzinga.com/news/m-a/18/07/11985555/zoetis-abaxis-receive-hart-scott-rodino-antitrust-clearance-for-deal | Benzinga Newsdesk | 2018-07-06T00:00:00 | ZTS |
1,412,235 | Hearing Zoetis Deal For Abaxis Has Been Challenged By Shareholder | https://www.benzinga.com/news/18/06/11946447/hearing-zoetis-deal-for-abaxis-has-been-challenged-by-shareholder | Benzinga Newsdesk | 2018-06-27T00:00:00 | ZTS |
1,412,236 | Stocks That Made New 52-Week Highs Today Include: Electronic Arts, Intuit, NetApp, Netflix, Republic Services, VeriSign, Union Pacific, Zoetis, Twenty-First Century Fox, Edward Lifesciences, Ansys, and Advance Auto Parts | https://www.benzinga.com/trading-ideas/technicals/18/06/11888557/stocks-that-made-new-52-week-highs-today-include-electronic- | Benzinga Newsdesk | 2018-06-15T00:00:00 | ZTS |
1,412,237 | Stocks That Made New 52 Week Highs Today Include: Zoetis, Fortive, VeriSign, CF Industries, Ansys, Facebook, IDEXX, Fiserv, Global Payments, CA, Akamai, AES, NVIDIA, Align Tech, and Adobe | https://www.benzinga.com/trading-ideas/technicals/18/06/11882608/stocks-that-made-new-52-week-highs-today-include-zoetis-fort | Benzinga Newsdesk | 2018-06-14T00:00:00 | ZTS |
1,412,238 | Regeneron, Zoetis Report Collaboration To Research Antibody Therapies For Use In Animal Health | https://www.benzinga.com/news/18/06/11836796/regeneron-zoetis-report-collaboration-to-research-antibody-therapies-for-use-in- | Benzinga Newsdesk | 2018-06-06T00:00:00 | ZTS |
1,412,239 | Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More | https://www.benzinga.com/general/biotech/18/05/11731569/benzingas-daily-biotech-pulse-asco-abstracts-fibrocell-ispen-and-more | Shanthi Rexaline | 2018-05-17T00:00:00 | ZTS |
1,412,240 | 41 Biggest Movers From Yesterday | https://www.benzinga.com/news/18/05/11731491/41-biggest-movers-from-yesterday | Lisa Levin | 2018-05-17T00:00:00 | ZTS |
1,412,241 | Mid-Afternoon Market Update: Blink Charging Rises After Q1 Results; Purple Innovation Shares Slide | https://www.benzinga.com/news/18/05/11727943/mid-afternoon-market-update-blink-charging-rises-after-q1-results-purple-innovat | Lisa Levin | 2018-05-16T00:00:00 | ZTS |
1,412,242 | 40 Stocks Moving In Wednesday's Mid-Day Session | https://www.benzinga.com/news/18/05/11727214/40-stocks-moving-in-wednesdays-mid-day-session | Lisa Levin | 2018-05-16T00:00:00 | ZTS |
1,412,243 | Mid-Day Market Update: Abaxis Climbs On Acquisition News; Evolus Shares Plunge | https://www.benzinga.com/news/18/05/11727139/mid-day-market-update-abaxis-climbs-on-acquisition-news-evolus-shares-plunge | Lisa Levin | 2018-05-16T00:00:00 | ZTS |
1,412,244 | Mid-Morning Market Update: Markets Edge Higher; Macy's Tops Q1 Estimates | https://www.benzinga.com/news/18/05/11726042/mid-morning-market-update-markets-edge-higher-macys-tops-q1-estimates | Lisa Levin | 2018-05-16T00:00:00 | ZTS |
1,412,245 | Zoetis To Buy Abaxis In $2 Billion Deal | https://www.benzinga.com/general/biotech/18/05/11724665/zoetis-to-buy-abaxis-in-2-billion-deal | Shanthi Rexaline | 2018-05-16T00:00:00 | ZTS |
1,412,246 | 26 Stocks Moving In Wednesday's Pre-Market Session | https://www.benzinga.com/news/18/05/11724568/26-stocks-moving-in-wednesdays-pre-market-session | Lisa Levin | 2018-05-16T00:00:00 | ZTS |
1,412,247 | A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Housing Starts, Industrial Production Data | https://www.benzinga.com/news/18/05/11724160/a-peek-into-the-markets-us-stock-futures-edge-higher-ahead-of-housing-starts-ind | Lisa Levin | 2018-05-16T00:00:00 | ZTS |
1,412,248 | Zoetis to Acquire Abaxis for $83/Share in Cash | https://www.benzinga.com/news/m-a/18/05/11724068/zoetis-to-acquire-abaxis-for-83share-in-cash | Benzinga Newdesk | 2018-05-16T00:00:00 | ZTS |
1,412,249 | Anatara Lifesciences Announces Exclusive Global License Agreement with Zoetis | https://www.benzinga.com/news/18/05/11711191/anatara-lifesciences-announces-exclusive-global-license-agreement-with-zoetis | Benzinga Newdesk | 2018-05-15T00:00:00 | ZTS |
1,412,250 | Zoetis Sees FY18 EPS $2.96-$3.10 vs $3.05 Est., Sales $5.675-$5.8B vs $5.74B Est. | https://www.benzinga.com/news/18/05/11624912/zoetis-sees-fy18-eps-2-96-3-10-vs-3-05-est-sales-5-675-5-8b-vs-5-74b-est | Eddie Staley | 2018-05-02T00:00:00 | ZTS |
1,412,251 | Zoetis Q1 EPS $0.75 Beats $0.69 Estimate, Sales $1.4B Beat $1.35B Estimate | https://www.benzinga.com/news/earnings/18/05/11624897/zoetis-q1-eps-0-75-beats-0-69-estimate-sales-1-4b-beat-1-35b-estimate | Eddie Staley | 2018-05-02T00:00:00 | ZTS |
1,412,252 | Earnings Scheduled For May 2, 2018 | https://www.benzinga.com/news/earnings/18/05/11624266/earnings-scheduled-for-may-2-2018 | Lisa Levin | 2018-05-02T00:00:00 | ZTS |
1,412,253 | Morgan Stanley: 11 High-Conviction Stocks To Watch This Earnings Season | https://www.benzinga.com/analyst-ratings/analyst-color/18/04/11537042/morgan-stanley-11-high-conviction-stocks-to-watch-this- | Wayne Duggan | 2018-04-22T00:00:00 | ZTS |
1,412,254 | Zoetis Shares Reach New 52-Week High of $85.74 | https://www.benzinga.com/trading-ideas/technicals/18/04/11531645/zoetis-shares-reach-new-52-week-high-of-85-74 | Hal Lindon | 2018-04-17T00:00:00 | ZTS |
1,412,255 | Stocks That Made New 52 Wk Highs Include Xylem, Zoetis, Marathon Petroleum, and Roper Technologies; New 52 Wk Lows For Procter & Gamble, Kimberly-Clark, Campbell's Soup, GE, and General Mills | https://www.benzinga.com/trading-ideas/technicals/18/03/11398022/stocks-that-made-new-52-wk-highs-include-xylem-zoetis-marath | Hal Lindon | 2018-03-21T00:00:00 | ZTS |
1,412,256 | Zoetis Downgraded As Valuation Approaches Morgan Stanley's Price Target | https://www.benzinga.com/analyst-ratings/analyst-color/18/03/11381697/zoetis-downgraded-as-valuation-approaches-morgan-stanle | Elizabeth Balboa | 2018-03-19T00:00:00 | ZTS |
1,412,257 | Benzinga's Top Upgrades, Downgrades For March 19, 2018 | https://www.benzinga.com/analyst-ratings/upgrades/18/03/11381723/benzingas-top-upgrades-downgrades-for-march-19-2018 | Lisa Levin | 2018-03-19T00:00:00 | ZTS |
1,412,258 | Morgan Stanley Downgrades Zoetis to Equal-Weight | https://www.benzinga.com/news/18/03/11380704/morgan-stanley-downgrades-zoetis-to-equal-weight | Eddie Staley | 2018-03-19T00:00:00 | ZTS |
1,412,259 | Stocks That Made New 52-Wk Highs Earlier Include: Accenture, Raytheon, PNC, M&T Bank, Comerica, Zions Bancorp, Moody's, SunTrust Banks, Fortive, Zoetis, Red Hat, Digital Realty Trust, Cognizant, Adobe, and Salesforce | https://www.benzinga.com/movers/18/02/11235377/stocks-that-made-new-52-wk-highs-earlier-include-accenture-raytheon-pnc-m-t-ba | Hal Lindon | 2018-02-21T00:00:00 | ZTS |
1,412,260 | Stocks That Made New 52-Wk Highs Earlier Today Include: Moody's, Adobe, Cognizant, Zoetis, Salesforce, NVIDIA, Red Hat, CSRA, Intuit, Coty, Garmin, Global Payments, and Ansys | https://www.benzinga.com/movers/18/02/11228378/stocks-that-made-new-52-wk-highs-earlier-today-include-moodys-adobe-cognizant- | Hal Lindon | 2018-02-20T00:00:00 | ZTS |
1,412,261 | Zoetis Sees FY18 Adj. EPS $2.96-$3.10 vs $2.98 Est., Sales $5.675B-$5.8B vs $5.61B Est. | https://www.benzinga.com/news/guidance/18/02/11207544/zoetis-sees-fy18-adj-eps-2-96-3-10-vs-2-98-est-sales-5-675b-5-8b-vs-5-6 | Paul Quintaro | 2018-02-15T00:00:00 | ZTS |
1,412,262 | Zoetis Reports Q4 Adj. EPS $0.69 vs $0.66 Est., Sales $1.5B vs $1.4B Est. | https://www.benzinga.com/news/earnings/18/02/11207542/zoetis-reports-q4-adj-eps-0-69-vs-0-66-est-sales-1-5b-vs-1-4b-est | Paul Quintaro | 2018-02-15T00:00:00 | ZTS |
1,412,263 | Earnings Scheduled For February 15, 2018 | https://www.benzinga.com/news/earnings/18/02/11206918/earnings-scheduled-for-february-15-2018 | Lisa Levin | 2018-02-15T00:00:00 | ZTS |
1,412,264 | Zoetis 8-K Shows Expectation For Net Reduction Not Exceeding $350M In Q4 GAAP Net Income Related To Repatriation Following Tax Cuts And Jobs Act | https://www.benzinga.com/news/guidance/18/01/11000002/zoetis-8-k-shows-expectation-for-net-reduction-not-exceeding-350m-in-q4 | Paul Quintaro | 2018-01-08T00:00:00 | ZTS |
1,412,265 | Zoetis Spikes to High of $73.08 on Volume; Activity in Jan 72.5 Call | https://www.benzinga.com/markets/options/17/12/10940641/zoetis-spikes-to-high-of-73-08-on-volume-activity-in-jan-72-5-call | Charles Gross | 2017-12-20T00:00:00 | ZTS |
1,412,266 | Zoetis Launches Vanguard CIV H3N2/H3N8 Vaccine for Canine Influenza Virus | https://www.benzinga.com/news/17/12/10902390/zoetis-launches-vanguard-civ-h3n2h3n8-vaccine-for-canine-influenza-virus | Eddie Staley | 2017-12-12T00:00:00 | ZTS |
1,412,267 | Zoetis Raises Qtr. Dividend From $.105/Share To $.0126/Share | https://www.benzinga.com/trading-ideas/dividends/17/12/10899670/zoetis-raises-qtr-dividend-from-105share-to-0126share | Hal Lindon | 2017-12-11T00:00:00 | ZTS |
1,412,268 | Analyst: Zoetis Deserves To Trade At A Premium | https://www.benzinga.com/analyst-ratings/analyst-color/17/11/10845530/analyst-zoetis-deserves-to-trade-at-a-premium | Jayson Derrick | 2017-11-29T00:00:00 | ZTS |
1,412,269 | Benzinga's Top Upgrades, Downgrades For November 29, 2017 | https://www.benzinga.com/analyst-ratings/upgrades/17/11/10845449/benzingas-top-upgrades-downgrades-for-november-29-2017 | Lisa Levin | 2017-11-29T00:00:00 | ZTS |
1,412,270 | Morgan Stanley Upgrades Zoetis to Overweight | https://www.benzinga.com/news/17/11/10844282/morgan-stanley-upgrades-zoetis-to-overweight | Paul Quintaro | 2017-11-29T00:00:00 | ZTS |
1,412,271 | UBS Downgrades Zoetis from Buy to Neutral | https://www.benzinga.com/analyst-ratings/downgrades/17/11/10829089/ubs-downgrades-zoetis-from-buy-to-neutral | Eddie Staley | 2017-11-24T00:00:00 | ZTS |
1,412,272 | Zoetis Sees FY17 Sales $5.225-$5.275B vs $5.2B Est., Adj. EPS $2.34-$2.39 vs $2.34 Est. | https://www.benzinga.com/news/guidance/17/11/10271295/zoetis-sees-fy17-sales-5-225-5-275b-vs-5-2b-est-adj-eps-2-34-2-39-vs-2- | Paul Quintaro | 2017-11-02T00:00:00 | ZTS |
1,412,273 | Zoetis Reports Q3 Adj. EPS $0.65 vs $0.62 Est., Sales $1.3B vs $1.32B Est. | https://www.benzinga.com/news/earnings/17/11/10271290/zoetis-reports-q3-adj-eps-0-65-vs-0-62-est-sales-1-3b-vs-1-32b-est | Paul Quintaro | 2017-11-02T00:00:00 | ZTS |
1,412,274 | Earnings Scheduled For November 2, 2017 | https://www.benzinga.com/news/earnings/17/11/10270558/earnings-scheduled-for-november-2-2017 | Lisa Levin | 2017-11-02T00:00:00 | ZTS |
1,412,275 | Zoetis Shares Spike 0.5% Higher Following Mention On CNBC's 'Fast Money Halftime Report' by Karen Firestone | https://www.benzinga.com/movers/17/10/10249352/zoetis-shares-spike-0-5-higher-following-mention-on-cnbcs-fast-money-halftime- | Paul Quintaro | 2017-10-30T00:00:00 | ZTS |
1,412,276 | Cantor Fitzgerald Global Healthcare Conference Continues Today, Presenters Include: Innoviva, Puma Biotech, Magellan Health, TherapeuticsMD, Zoetis, Aurinia Pharma and Celgene | https://www.benzinga.com/general/biotech/17/09/10100750/cantor-fitzgerald-global-healthcare-conference-continues-today-presen | Hal Lindon | 2017-09-26T00:00:00 | ZTS |
1,412,277 | VCA Announces Its VCA Animal Hospitals Unit To Partner With Zoetis Related To Successful Clinical Study On Clavamox Chewable Antibiotic Tablets | https://www.benzinga.com/news/fda/17/08/9925730/vca-announces-its-vca-animal-hospitals-unit-to-partner-with-zoetis-related-to | Paul Quintaro | 2017-08-14T00:00:00 | ZTS |
1,412,278 | Zoetis Sees FY17 Sales $5.15-$5.25B vs $5.19B Est., Adj. EPS $2.30-$2.37 vs $2.33 Est. | https://www.benzinga.com/news/guidance/17/08/9892610/zoetis-sees-fy17-sales-5-15-5-25b-vs-5-19b-est-adj-eps-2-30-2-37-vs-2-33 | Paul Quintaro | 2017-08-08T00:00:00 | ZTS |
1,412,279 | Zoetis Reports Q2 Adj. EPS $0.53 vs $0.53 Est., Sales $1.3B vs $1.27B Est. | https://www.benzinga.com/news/earnings/17/08/9892607/zoetis-reports-q2-adj-eps-0-53-vs-0-53-est-sales-1-3b-vs-1-27b-est | Paul Quintaro | 2017-08-08T00:00:00 | ZTS |
1,412,280 | Earnings Scheduled For August 8, 2017 | https://www.benzinga.com/news/earnings/17/08/9891656/earnings-scheduled-for-august-8-2017 | Lisa Levin | 2017-08-08T00:00:00 | ZTS |
1,412,281 | Watch These 7 Huge Call Purchases In Tuesday Trade | https://www.benzinga.com/markets/options/17/08/9891627/watch-these-7-huge-call-purchases-in-tuesday-trade | Lisa Levin | 2017-08-08T00:00:00 | ZTS |
1,412,282 | Zoetis Option Alert: Aug 18 $60.5 Calls Sweep (30) at the Ask: 597 @ $1.996 vs 0 OI; Ref=$61.67 | https://www.benzinga.com/markets/options/17/08/9888740/zoetis-option-alert-aug-18-60-5-calls-sweep-30-at-the-ask-597-1-996-vs | Charles Gross | 2017-08-07T00:00:00 | ZTS |
1,412,283 | Zoetis Investors May Need Patience To See Bull Thesis Play Out | https://www.benzinga.com/analyst-ratings/analyst-color/17/07/9824398/zoetis-investors-may-need-patience-to-see-bull-thesis-pl | Jayson Derrick | 2017-07-26T00:00:00 | ZTS |
1,412,284 | Benzinga's Top Upgrades, Downgrades For July 26, 2017 | https://www.benzinga.com/analyst-ratings/upgrades/17/07/9823964/benzingas-top-upgrades-downgrades-for-july-26-2017 | Lisa Levin | 2017-07-26T00:00:00 | ZTS |
1,412,285 | The Market In 5 Minutes | https://www.benzinga.com/news/17/07/9822763/the-market-in-5-minutes | Benzinga News Desk | 2017-07-26T00:00:00 | ZTS |
1,412,286 | Deutsche Bank Downgrades Zoetis to Hold | https://www.benzinga.com/news/17/07/9822250/deutsche-bank-downgrades-zoetis-to-hold | Paul Quintaro | 2017-07-26T00:00:00 | ZTS |
1,412,287 | Top Research Reports for UnitedHealth, Netflix & Pepsi | https://www.benzinga.com/17/06/9633989/top-research-reports-for-unitedhealth-netflix-pepsi | Zacks | 2017-06-20T00:00:00 | ZTS |
1,412,288 | Cantor Fitzgerald Initiates Coverage On Zoetis with Overweight Rating, Announces $75.00 Price Target | https://www.benzinga.com/news/17/06/9617761/cantor-fitzgerald-initiates-coverage-on-zoetis-with-overweight-rating-announces-7 | Hal Lindon | 2017-06-16T00:00:00 | ZTS |
1,412,289 | Celgene (CELG) Reports Data on Lupus Drug in Phase II Trial | https://www.benzinga.com/17/06/9616942/celgene-celg-reports-data-on-lupus-drug-in-phase-ii-trial | Zacks | 2017-06-15T00:00:00 | ZTS |
1,412,290 | Looking For A Better Entry Point, BMO Downgrades Zoetis Shares | https://www.benzinga.com/analyst-ratings/analyst-color/17/06/9601947/looking-for-a-better-entry-point-bmo-downgrades-zoetis-s | Merrick Weingarten | 2017-06-13T00:00:00 | ZTS |
1,412,291 | Benzinga's Top Upgrades, Downgrades For June 13, 2017 | https://www.benzinga.com/analyst-ratings/upgrades/17/06/9601469/benzingas-top-upgrades-downgrades-for-june-13-2017 | Lisa Levin | 2017-06-13T00:00:00 | ZTS |
1,412,292 | BMO Capital Downgrades Zoetis to Market Perform | https://www.benzinga.com/news/17/06/9600273/bmo-capital-downgrades-zoetis-to-market-perform | Hal Lindon | 2017-06-13T00:00:00 | ZTS |
1,412,293 | Adamas Provides Positive Long-term Data on Parkinson's Drug | https://www.benzinga.com/17/06/9588460/adamas-provides-positive-long-term-data-on-parkinsons-drug | Zacks | 2017-06-09T00:00:00 | ZTS |
1,412,294 | Zoetis (ZTS) Up 6.4% Since Earnings Report: Can It Continue? | https://www.benzinga.com/17/06/9581606/zoetis-zts-up-6-4-since-earnings-report-can-it-continue | Zacks | 2017-06-08T00:00:00 | ZTS |
1,412,295 | Jazz Pharma Sleep Disorder Candidate Positive in Phase III | https://www.benzinga.com/17/06/9577648/jazz-pharma-sleep-disorder-candidate-positive-in-phase-iii | Zacks | 2017-06-07T00:00:00 | ZTS |
1,412,296 | Benzinga's Top Upgrades, Downgrades For May 26, 2017 | https://www.benzinga.com/analyst-ratings/upgrades/17/05/9526561/benzingas-top-upgrades-downgrades-for-may-26-2017 | Lisa Levin | 2017-05-26T00:00:00 | ZTS |
1,412,297 | CL King Initiates Coverage On Zoetis with Buy Rating, Announces $71.00 Price Target | https://www.benzinga.com/news/17/05/9526064/cl-king-initiates-coverage-on-zoetis-with-buy-rating-announces-71-00-price-target | Hal Lindon | 2017-05-26T00:00:00 | ZTS |
1,412,298 | Watch These 7 Huge Put Purchases In Friday Trade | https://www.benzinga.com/markets/options/17/05/9525218/watch-these-7-huge-put-purchases-in-friday-trade | Lisa Levin | 2017-05-26T00:00:00 | ZTS |
1,412,299 | Benzinga's Option Alert Recap From May 25 | https://www.benzinga.com/news/17/05/9523282/benzingas-option-alert-recap-from-may-25 | Javier Hasse | 2017-05-25T00:00:00 | ZTS |
1,412,300 | Option Alert: Zoetis Jan18 60.0 Puts Sweep: 623 @ ASK $2.55: 736 traded vs 128 OI: Earnings 8/3 Before Open (est) $62.38 Ref | https://www.benzinga.com/markets/options/17/05/9521760/option-alert-zoetis-jan18-60-0-puts-sweep-623-ask-2-55-736-traded-vs-1 | Charles Gross | 2017-05-25T00:00:00 | ZTS |
1,412,301 | Zoetis Announces Will Receive $14.4M Grant from Bill & Melinda Gates Foundation Over Next 3 Years for Development of Veterinary Diagnostic Networks, Animal Health Infrastructure in Ethiopia, Nigeria, Uganda | https://www.benzinga.com/news/17/05/9420900/zoetis-announces-will-receive-14-4m-grant-from-bill-melinda-gates-foundation-over | Paul Quintaro | 2017-05-08T00:00:00 | ZTS |
1,412,302 | Zoetis Reaffirms FY17 Outlook: Adj. EPS $2.26-$2.36 vs $2.32 Est., Sales $5.1B-$5.225B | https://www.benzinga.com/news/guidance/17/05/9400803/zoetis-reaffirms-fy17-outlook-adj-eps-2-26-2-36-vs-2-32-est-sales-5-1b-5 | Paul Quintaro | 2017-05-04T00:00:00 | ZTS |
1,412,303 | Zoetis Reports Q1 EPS $0.48, Inline, Sales $1.2B vs $1.19B Est. | https://www.benzinga.com/news/earnings/17/05/9400793/zoetis-reports-q1-eps-0-48-inline-sales-1-2b-vs-1-19b-est | Paul Quintaro | 2017-05-04T00:00:00 | ZTS |
1,412,304 | Watch These 8 Huge Call Purchases In Friday Trade | https://www.benzinga.com/markets/options/17/04/9363972/watch-these-8-huge-call-purchases-in-friday-trade | Lisa Levin | 2017-04-28T00:00:00 | ZTS |
1,412,305 | Benzinga's Option Alert Recap From April 27 | https://www.benzinga.com/news/17/04/9362080/benzingas-option-alert-recap-from-april-27 | Javier Hasse | 2017-04-27T00:00:00 | ZTS |
1,412,306 | Zoetis Shares Up 1.3% As Animal Pharm Reported That Zoetis Received Authorization For First mAB for Vet Use In Europe | https://www.benzinga.com/news/fda/17/04/9358323/zoetis-shares-up-1-3-as-animal-pharm-reported-that-zoetis-received-authorizat | Paul Quintaro | 2017-04-27T00:00:00 | ZTS |
1,412,307 | Option Alert: Zoetis May 57.5 Calls Sweep: 731 @ ASK $0.75: 731 traded vs 33 OI: Earnings 5/4 Before Open $56.26 Ref | https://www.benzinga.com/markets/options/17/04/9358278/option-alert-zoetis-may-57-5-calls-sweep-731-ask-0-75-731-traded-vs-33 | Charles Gross | 2017-04-27T00:00:00 | ZTS |
1,412,308 | Option Alert: Zoetis May 5th 56.0 Calls Sweep: 2801 @ ASK $0.95: 2801 traded vs 28 OI: Earnings 5/4 Before Open $55.76 Ref | https://www.benzinga.com/markets/options/17/04/9357146/option-alert-zoetis-may-5th-56-0-calls-sweep-2801-ask-0-95-2801-traded | Charles Gross | 2017-04-27T00:00:00 | ZTS |
1,412,309 | Zoetis Reports Received EC Market Authorization for Cytopoint | https://www.benzinga.com/news/17/04/9352376/zoetis-reports-received-ec-market-authorization-for-cytopoint | Paul Quintaro | 2017-04-26T00:00:00 | ZTS |
1,412,310 | 10 Biggest Mid-Day Gainers For Thursday | https://www.benzinga.com/news/17/04/9298886/10-biggest-mid-day-gainers-for-thursday | Jim Swanson | 2017-04-13T00:00:00 | ZTS |
1,412,311 | Zoetis Reports Purchase of Nexvet Biopharma for $6.72/Share, or ~$85M Deal | https://www.benzinga.com/news/m-a/17/04/9297500/zoetis-reports-purchase-of-nexvet-biopharma-for-6-72share-or-85m-deal | Paul Quintaro | 2017-04-13T00:00:00 | ZTS |
1,412,312 | Zoetis Drops to Low of $53.72 on Volume | https://www.benzinga.com/movers/17/03/9231717/zoetis-drops-to-low-of-53-72-on-volume | Charles Gross | 2017-03-29T00:00:00 | ZTS |
1,412,313 | Benzinga's Top Upgrades, Downgrades For March 16, 2017 | https://www.benzinga.com/analyst-ratings/upgrades/17/03/9180145/benzingas-top-upgrades-downgrades-for-march-16-2017 | Lisa Levin | 2017-03-16T00:00:00 | ZTS |
1,412,314 | Craig-Hallum Initiates Coverage On Zoetis With Buy, Announces $65 Price Target | https://www.benzinga.com/news/17/03/9178868/craig-hallum-initiates-coverage-on-zoetis-with-buy-announces-65-price-target | Paul Quintaro | 2017-03-16T00:00:00 | ZTS |
1,412,315 | Cowen Annual Healthcare Conference Begins Today; Presenters Include Insulet, PARAXEL, Zoetis, Alexion, Bristol-Myers, Acadia, Alnylam, Axovant, Ardelyx, Aurinia Pharma, And Puma Biotech | https://www.benzinga.com/news/17/03/9132598/cowen-annual-healthcare-conference-begins-today-presenters-include-insulet-paraxe | Hal Lindon | 2017-03-06T00:00:00 | ZTS |
1,412,316 | Q4 2016 Real-Time Call Brief | https://www.benzinga.com/node/9059627 | Scout Finance | 2017-02-16T00:00:00 | ZTS |
1,412,317 | Zoetis Sees FY17 Revenue $5.1-$5.225B vs. $5.18B, Adj. EPS $2.26-$2.36 vs. $2.33 Est. | https://www.benzinga.com/news/guidance/17/02/9058292/zoetis-sees-fy17-revenue-5-1-5-225b-vs-5-18b-adj-eps-2-26-2-36-vs-2-33-e | Paul Quintaro | 2017-02-16T00:00:00 | ZTS |
1,412,318 | Zoetis Reports Q4 Adj. EPS $0.47 vs. $0.45 Est., Rev. $1.3B vs. $1.27B Est. | https://www.benzinga.com/news/earnings/17/02/9058267/zoetis-reports-q4-adj-eps-0-47-vs-0-45-est-rev-1-3b-vs-1-27b-est | Paul Quintaro | 2017-02-16T00:00:00 | ZTS |
1,412,319 | Zoetis Reports Received EC Approval for Stronghold Plus | https://www.benzinga.com/news/17/02/9055869/zoetis-reports-received-ec-approval-for-stronghold-plus | Paul Quintaro | 2017-02-15T00:00:00 | ZTS |
1,412,320 | Watch These 8 Huge Call Purchases In Monday Trade | https://www.benzinga.com/markets/options/17/01/8931653/watch-these-8-huge-call-purchases-in-monday-trade | Lisa Levin | 2017-01-23T00:00:00 | ZTS |